Memantine treatment in alcohol dementia: rapid PET changes and clinical course.
نویسندگان
چکیده
Alcohol dementia (ALD) usually follows long-term alcohol dependence. The major psychiatric features of ALD are general loss of short-and long-term memory combined with disturbances in concentration and a decrease in intellectual capacity, all of which persist during abstinence. Despite its clinical importance, few studies have been published up to now on medical treatment of ALD and other alcohol-induced mental disorders [1]. The central nervous gluta-matergic system, with its N-methyl-D-aspartate (NMDA) receptors, is suggested to be involved in toxic neuronal loss [2] due to an increased glutamatergic neurotransmission during repeated alcohol withdrawal and may subsequently contribute to the development of ALD. The low-affinity NMDA receptor antagonist memantine (ada-mantine, 1-amino-3,5-dimethyladamantine hydrochloride, CAS 41100-52-1) modulates the glutamatergic system most likely through Ca 2+ influx blockage of NMDA receptors [3] and shows positive effects on memory in the treatment of other psychogeriatric disorders with memory loss such as Alzheimer's dementia (AD) or Parkinson's disease [4]. We would like to report the case of a 71-year-old female patient with chronic alcoholism for at least 30 years. She was found neglected in her home and was admitted to our ward from an emergency unit with symptoms of disorientation, apraxia, ataxia, severe short-and long-term memory disturbances, deficits in intellectual capacity and concentration. There were no signs of electrolyte imbalance on admission. A further thorough neurological investigation and NMR showed a general atrophy without severe basal brain damage of Wer-nicke encephalopathy. No other signs of Wernicke encephalopathy, i.e. ophthalmoplegia or evidence of hepatic encephalopathy such as flapping tremor, were found. Ultrasound of brain arteries showed some plaques without hemodynamic compromise. After excluding Alzheimer's disease or vascular dementia, the diagnosis of ALD according to ICD10 criteria was made.
منابع مشابه
The Effects of Donepezil, Galantamine, Rivastigmine and Memantine on Mini-Mental State Examination and Mean Flow Velocity in Patients with Vascular Dementia: A Double-Blinded Randomized Clinical Trial
Background: Vascular dementia is one of the most common forms of dementia. At now, there is no treatment available to cure vascular dementia or to alter its clinical course. Some studies suggest that some drugs may be useful in controlling symptoms. The aim of this study was to evaluate the effects of donepezil, memantine, rivastigmine and galantamine on mean flow velocity and ...
متن کاملOpen-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
BACKGROUND Memantine has shown effects on cortical metabolism in Alzheimer's disease (AD), and the mechanism of action may not be specific to AD alone. We hypothesized that participants with frontotemporal dementia taking memantine would show an increased cortical metabolic activity in frontal regions, temporal regions, or in salience network hubs. METHODS Sixteen participants with behavioral...
متن کاملMemantine hydrochloride in the treatment of dementia subtypes.
Memantine hydrochloride is a first-line therapeutic drug approved by the US Food and Drug Administration for the management of moderate to severe Alzheimer's disease (AD). We conducted a review of the literature to determine the changes to the central glutamatergic neurotransmitter system in dementia subtypes and the available clinical evidence regarding the use of memantine in the treatment of...
متن کاملRecent Advances in the Management of Alzheimer’s Disease
Alzheimer’s disease is a disease of the elderly, mainly affecting people above 60 years of age. It is turning out to be a major public health problem with an estimated 4.7% of the population above 60 years of age (35.6 million) worldwide to be affected by dementia in 2010. The clinical diagnosis is basically a diagnosis of exclusion using various memory tests like MMSE (Mini Mental Score Examin...
متن کاملBiomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer’s Disease
Degerman Gunnarsson, M. 2013. Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer’s Disease. Acta Universitatis Upsaliensis. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 881. 65 pp. Uppsala. ISBN 978-91-554-8629-7. Decreased amyloid-ß42 (Aß42), increased total tau (t-tau) and phosphorylated tau (p-tau...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- European neurology
دوره 45 1 شماره
صفحات -
تاریخ انتشار 2001